====== UMK57 1μM R01 exp59 ====== ==== Mechanism of Action ==== Potentiates kinesin-13 (MCAK), destabilizes kinetochore-MT attachment, suppresses chromosome mis-segregation * **Class / Subclass 1:** Cell Cycle / Mitotic Inhibitor * **Class / Subclass 2:** Organelle Function / Cytoskeletal Inhibitor ==== Technical Notes ==== * **PubChem Name:** %%5-(4-Methylphenyl)-4-pyrrolidinylthiopheno[2,3-d]pyrimidine%% * **Synonyms:** N/A * **CAS #:** 342595-74-8 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/693939|693939]] * **IUPAC:** %%5-(4-methylphenyl)-4-pyrrolidin-1-ylthieno[2,3-d]pyrimidine%% * **INCHI Name:** InChI=1S/C17H17N3S/c1-12-4-6-13(7-5-12)14-10-21-17-15(14)16(18-11-19-17)20-8-2-3-9-20/h4-7,10-11H,2-3,8-9H2,1H3 * **INCHI Key:** VOAWQTDHSSKEKA-UHFFFAOYSA-N * **Molecular Weight:** 295.4 * **Canonical SMILES:** CC1=CC=C(C=C1)C2=CSC3=NC=NC(=C23)N4CCCC4 * **Isomeric SMILES:** N/A * **Molecular Formula:** C17H17N3S {{:chemogenomics:structures:chem-0039.svg?nolink}} * **Supplier Name:** In house - University of Montreal - Chemistry Platform * **Catalog #:** N/A * **Lot #:** N/A * **HRMS (ESI-TOF) m/z:** [M+H]+ Calcd for C17H18N3S 296.1216; found 296.1142 * **Platform ID:** UMK57 * **Min:** -2.8530; **Max:** 75.4945 {{:chemogenomics:dose_response:dr_159.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |0.3698 | | IC30 |0.6436 | | IC40 |1.0136 | | IC50 |1.5379 | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ ==== Screen Summary ==== * **Round**: 01 * **Dose**: 1µM * **Days of incubation**: 8 * **Doublings**: 5.2 * **Numbers of reads**: 15049192 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |27/49|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/UMK57_1uM_Round-1_exp59.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp59.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:D:DLGAP5|DLGAP5]]|-3.66|<0.01| |[[:human_genes:Y:YPEL5|YPEL5]]|-3.46|<0.01| |[[:human_genes:A:ARID4B|ARID4B]]|-3.31|<0.01| |[[:human_genes:W:WDR61|WDR61]]|-3.27|0.02| |[[:human_genes:A:ASPM|ASPM]]|-3.17|0.03| |[[:human_genes:P:PDS5B|PDS5B]]|-3.10|0.01| |[[:human_genes:T:TRIP13|TRIP13]]|-3.09|0.01| |[[:human_genes:B:BRD1|BRD1]]|-3.08|<0.01| |[[:human_genes:R:RNF111|RNF111]]|-3.06|<0.01| |[[:human_genes:G:GTSE1|GTSE1]]|-2.98|0.02| |[[:human_genes:P:PCGF1|PCGF1]]|-2.96|0.01| |[[:human_genes:I:IPO11|IPO11]]|-2.92|0.03| |[[:human_genes:I:ITPK1|ITPK1]]|-2.86|0.03| |[[:human_genes:C:CNOT2|CNOT2]]|-2.83|0.03| |[[:human_genes:N:NELFE|NELFE]]|-2.76|0.03| |[[:human_genes:U:UBE2H|UBE2H]]|-2.74|0.03| |[[:human_genes:W:WDR26|WDR26]]|-2.74|0.05| |[[:human_genes:Z:ZNF367|ZNF367]]|-2.70|0.03| |[[:human_genes:R:RBM26|RBM26]]|-2.62|0.04| |[[:human_genes:M:MSI2|MSI2]]|-2.60|0.03| |[[:human_genes:N:NMRK2|NMRK2]]|-2.58|0.05| |[[:human_genes:G:GAK|GAK]]|-2.56|0.03| |[[:human_genes:T:TCF4|TCF4]]|-2.54|0.03| |[[:human_genes:P:PPIL1|PPIL1]]|-2.54|0.10| |[[:human_genes:I:IKZF2|IKZF2]]|-2.54|0.03| |[[:human_genes:M:MAFF|MAFF]]|-2.53|0.19| |[[:human_genes:C:CTTNBP2|CTTNBP2]]|-2.53|0.05| |[[:human_genes:D:DNAJC9|DNAJC9]]|-2.51|0.04| |[[:human_genes:C:CD2BP2|CD2BP2]]|-2.45|0.22| |[[:human_genes:R:RING1|RING1]]|-2.44|0.05| |[[:human_genes:T:TLE4|TLE4]]|2.82|0.03| |[[:human_genes:C:CYB5R4|CYB5R4]]|2.83|<0.01| |[[:human_genes:A:ATXN7L3|ATXN7L3]]|2.83|0.01| |[[:human_genes:C:C21orf140|C21orf140]]|2.84|0.03| |[[:human_genes:L:LDLR|LDLR]]|2.84|<0.01| |[[:human_genes:C:CBX3|CBX3]]|2.87|<0.01| |[[:human_genes:S:SP3|SP3]]|2.87|0.01| |[[:human_genes:K:KHDRBS1|KHDRBS1]]|2.88|0.01| |[[:human_genes:K:KIFC1|KIFC1]]|2.88|<0.01| |[[:human_genes:P:PPP1R2|PPP1R2]]|2.94|<0.01| |[[:human_genes:A:ARIH1|ARIH1]]|3.02|0.01| |[[:human_genes:A:ATP1A1|ATP1A1]]|3.05|<0.01| |[[:human_genes:P:PPP6R3|PPP6R3]]|3.05|<0.01| |[[:human_genes:S:SLC25A51|SLC25A51]]|3.10|<0.01| |[[:human_genes:S:SETDB1|SETDB1]]|3.14|<0.01| |[[:human_genes:A:ATF7IP|ATF7IP]]|3.18|<0.01| |[[:human_genes:P:PPP2R4|PPP2R4]]|3.37|<0.01| |[[:human_genes:A:AMBRA1|AMBRA1]]|3.39|<0.01| |[[:human_genes:K:KIF2A|KIF2A]]|3.41|<0.01| |[[:human_genes:M:MAPRE1|MAPRE1]]|3.58|<0.01| |[[:human_genes:I:ID3|ID3]]|3.59|<0.01| |[[:human_genes:C:CCNF|CCNF]]|3.82|<0.01| |[[:human_genes:T:TP53|TP53]]|3.86|<0.01| |[[:human_genes:P:PPME1|PPME1]]|4.11|<0.01| |[[:human_genes:T:TIPRL|TIPRL]]|4.15|<0.01| |[[:human_genes:K:KIF2C|KIF2C]]|4.44|<0.01| |[[:human_genes:A:ATAT1|ATAT1]]|5.14|<0.01| |[[:human_genes:P:PPP2R1A|PPP2R1A]]|5.14|<0.01| |[[:human_genes:L:LCMT1|LCMT1]]|5.73|<0.01| |[[:human_genes:K:KIF18B|KIF18B]]|7.13|<0.01| ^Screen^Correlation^Plot^ |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|0.126|| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|0.07|| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|0.216|| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|0.172|| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|0.14|| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|0.13|| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|0.12|| |[[:results:exp517|Quercetin 20μM R08 exp517]]|0.105|| |[[:results:exp67|BVD-523 15μM R02 exp67]]|0.098|| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|0.096|| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|0.085|| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|0.081|| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|0.08|| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|0.078|| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|0.074|| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|0.074|| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|0.069|| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|0.06|| |[[:results:exp502|Milciclib 2μM R08 exp502]]|0.058|| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|0.058|| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|0.055|| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|0.054|| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|0.054|| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|0.053|| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|0.053|| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|0.052|| |[[:results:exp290|LLY-283 2.6μM R06 exp290]]|0.051|| {{:chemogenomics:comparison_plots:exp59_vs_exp60.png?nolink |}} {{:chemogenomics:comparison_plots:exp190_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp217_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp460_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp106_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp312_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp46_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp517_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp59_vs_exp67.png?nolink |}} {{:chemogenomics:comparison_plots:exp179_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp215_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp228_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp311_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp103_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp184_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp310_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp59_vs_exp80.png?nolink |}} {{:chemogenomics:comparison_plots:exp500_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp502_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp175_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp329_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp59_vs_exp78.png?nolink |}} {{:chemogenomics:comparison_plots:exp45_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp529_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp231_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp3_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp290_vs_exp59.png?nolink |}} No GO term hits below threshold. (FDR <0.05) ^GO Term^Fold Change^Genes^ |microtubule plus-end|71.99|KIF18B,KIF2C,MAPRE1| |regulation of phosphoprotein phosphatase activity|51.34|TIPRL,PTPA,PPP6R3,PPP1R2| |kinesin complex|50.17|KIF18B,KIF2C,KIF2A,KIFC1| |regulation of phosphatase activity|38.73|TIPRL,PTPA,PPP6R3,PPP1R2| |regulation of protein dephosphorylation|38.33|TIPRL,AMBRA1,PTPA,PPP6R3,PPP1R2| |microtubule motor activity|33.45|KIF18B,KIF2C,KIF2A,KIFC1| |protein phosphatase regulator activity|32.85|PPP2R1A,PPME1,PTPA,PPP6R3,PPP1R2| |phosphatase regulator activity|28.74|PPP2R1A,PPME1,PTPA,PPP6R3,PPP1R2| |regulation of dephosphorylation|27.87|TIPRL,AMBRA1,PTPA,PPP6R3,PPP1R2| |mitotic sister chromatid segregation|24.71|KIF18B,PPP2R1A,KIF2C,MAPRE1,KIF2A,KIFC1| |sister chromatid segregation|24.00|KIF18B,PPP2R1A,KIF2C,MAPRE1,KIF2A,KIFC1| |protein phosphatase binding|20.29|PPME1,TP53,AMBRA1,PTPA,PPP6R3| |mitotic nuclear division|17.14|KIF18B,KIF2C,MAPRE1,KIF2A,KIFC1| |nuclear chromosome segregation|15.33|KIF18B,PPP2R1A,KIF2C,MAPRE1,KIF2A,KIFC1| |mitotic cell cycle process|12.94|KIF18B,LCMT1,PPP2R1A,KIF2C,PPME1,TP53,CCNF,MAPRE1,KIF2A,PTPA,KIFC1,KHDRBS1| |mitotic cell cycle|11.11|KIF18B,LCMT1,PPP2R1A,KIF2C,PPME1,TP53,CCNF,MAPRE1,KIF2A,PTPA,KIFC1,KHDRBS1| |spindle|9.35|KIF18B,ATAT1,KIF2C,MAPRE1,KIF2A,KIFC1,CBX3| |microtubule cytoskeleton organization|8.24|KIF18B,PPP2R1A,ATAT1,KIF2C,MAPRE1,KIF2A,PTPA,KIFC1| |cell cycle process|7.64|KIF18B,LCMT1,PPP2R1A,KIF2C,PPME1,TP53,CCNF,MAPRE1,KIF2A,PTPA,KIFC1,KHDRBS1|